Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioatla Inc (NQ: BCAB )

1.690 +0.060 (+3.68%)
Streaming Delayed Price Updated: 10:21 AM EDT, Sep 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bioatla Inc

< Previous 1 2 3 4 Next >
BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody
From Context Therapeutics Inc.
Via GlobeNewswire
'Big Short' Fame Michael Burry Bets Big On China, Reveals Alibaba As Top Holding — JD.com And Baidu Also Feature On Scion's Portfolio
Famed investor Michael Burry, known for his prescient bet against the housing market before the 2008 financial crisis, has made significant changes to his hedge fund's portfolio in the second quarter... 
Via Benzinga
BCAB Stock Earnings: BioAtla Meets EPS for Q2 2024
BCAB stock results show that BioAtla met analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
BCAB Stock Earnings: BioAtla Beats EPS for Q1 2024
BCAB stock results show that BioAtla beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
BCAB Stock Earnings: BioAtla Beats EPS for Q4 2023
BCAB stock results show that BioAtla beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
BioAtla: Q4 Earnings Insights
Via Benzinga
Preview: BioAtla's Earnings
Via Benzinga
Analyst Ratings for BioAtla
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
The Latest Analyst Ratings for BioAtla
Via Benzinga
Where BioAtla Stands With Analysts
Via Benzinga
Earnings Scheduled For March 26, 2024
Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event
From BioAtla, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the Jefferies London Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award
Award recognizes Dr. Short’s contribution to science innovation 
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Provides Guidance on Near-Term Milestones and Plans to Announce Third Quarter 2023 Financial Results and Business Update on November 7, 2023
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in Upcoming Investor Conferences in August
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the Jefferies Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.